Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects

Cellular and Molecular Life Sciences

Volumn 73, Issue 20, 2016, Pages 3823-3837

  Comptour, Aurélie ^a   Rouzaire, Marion ^a   Belville, Corinne ^a   Bouvier, Damien ^a,b   Gallot, Denis ^a,b   Blanchon, Loïc ^a   Sapin, Vincent ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c Faculté de Médecine   (France)

Author keywords

Agonists; Antagonists; Placentation; Retinoid receptors; Vitamin A

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALITRETINOIN; BMS 493; BMS 614; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; UNCLASSIFIED DRUG; CELL RECEPTOR; DRUG;

FETUS DEVELOPMENT; HUMAN; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TERATOGENICITY; VITAMIN METABOLISM; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; FEMALE; METABOLISM; PLACENTA; REPRODUCTION; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; FEMALE; HUMANS; PHARMACEUTICAL PREPARATIONS; PLACENTA; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; REPRODUCTION; SPECIES SPECIFICITY;

EID: 84981274813     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2332-9     Document Type: Review

References (170)

1. Hale F (1933) Pigs born without eyeballs. J Heredity 24:105
2. Deligdish L (1992) Pathology of the placenta. In: Pasqualini JRT, Scholler R (eds) Hormone and fetal pathophysiology. Marcel Dekker Inc., New York, pp 203–249
3. Rinkenberger JL, Cross JC, Werb Z (1997) Molecular genetics of implantation in the mouse. Dev Genet 21:6–20
4. Kaufmann P, Burton G (1994) Anatomy and genesis of the placenta. In: Knobil E, Neill JD (eds) The physiology of reproduction, 2nd edn. Raven Press Ltd, New York, pp 441–484
5. Enders AC, Blankenship TN (2012) Interstitial trophoblast cells: an enigmatic and variable component of the developing macaque placenta. Placenta 9:672–676
6. Enders AC, Carter AM (2012) The evolving placenta: convergent evolution of variations in the endotheliochorial relationship. Placenta 5:319–326
7. Carter AM, Croy BA, Dantzer V, Enders AC, Hayakawa S, Mess A, Soma H (2007) Comparative aspects of placental evolution: a workshop report. Placenta, pp 129–132
8. Bauer MK, Harding JE, Bassett NS, Breier BH, Oliver MH, Gallaher BH, Evans PC, Woodall SM, Gluckman PD (1998) Fetal growth and placental function. Mol Cell Endocrinol 140:115–120
9. Gude NM, Roberts CT, Kalionis B, King RG (2004) Growth and function of the normal human placenta. Thromb Res 114:397–407
10. Zeldovich VB, Clausen CH, Bradford E, Fletcher DA, Maltepe E, Robbins JR, Bakardjiev AI (2013) Placental syncytium forms a biophysical barrier against pathogen invasion. PLoS Pathog 9:12
11. Caserta D, Graziano A, Monte GL, Bordi G, Moscarini M (2013) Heavy metals and placental fetal-maternal barrier: a mini-review on the major concerns. Eur Rev Med Pharmacol Sci 17:2198–2206
12. Evain-Brion D, Malassine A (2003) Human placenta as an endocrine organ. Growth Horm IGF Res 13:34–37
13. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ (1982) Early embryonic mortality in women. Fertil Steril 4:447–453
14. Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG (1996) Estimates of human fertility and pregnancy loss. Fertil Steril 3:503–509
15. Sapin V, Blanchon L, Serre AF, Lémery D, Dastugue B, Ward SW (2001) Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies? Transgenic Res 10:377–398
16. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635–641
17. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134–139
18. Khan SH, Arnott JA, Kumar R (2011) Naturally occurring osmolyte, trehalose induces functional conformation in an intrinsically disordered activation domain of glucocorticoid receptor. PLoS One 6:e19689
19. Bastien J, Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1–16
20. Zechel C, Shen XQ, Chambon P, Gronemeyer H (1994) Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J 13:1414–1424
21. Beato M (1991) Transcriptional control by nuclear receptors. FASEB J 5:2044–2051
22. Rastinejad F, Perlmann T, Evans RM, Sigler PB (1995) Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203–211
23. Koenig RJ, Brent GA, Warne RL, Larsen PR, Moore DD (1987) Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormone. Proc Natl Acad Sci 84:5670–5674
24. Umesono K, Murakami KK, Thompson CC, Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255–1266
25. Sladek R, Bader JA, Giguère V (1997) The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 17:5400–5409
26. Klaholz BP, Renaud JP, Mitschler A, Zusi C, Chambon P, Gronemeyer H, Moras D (1998) Conformational adaptation of agonists to the human nuclear receptor RAR gamma. Nat Struct Biol 5:199–202
27. Lavery DN, McEwan IJ (2005) Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J 391:449–464
28. Verhoeven G, Willems A, Denolet E, Swinnen JV, DeGendt K (2010) Androgens and spermatogenesis: lessons from transgenic mouse models. Philos Trans R Soc Lond B Biol Sci 365:1537–1556
29. Borel V, Gallot D, Marceau G, Sapin V, Blanchon L (2008) Placental implications of peroxisome proliferator-activated receptors in gestation and parturition. PPAR Res 2008:758562
30. Serpente P, Tümpel S, Ghyselinck NB, Niederreither K, Wiedemann LM, Dollé P, Chambon P, Krumlauf R, Gould AP (2005) Direct crossregulation between retinoic acid receptor beta and Hox genes during hindbrain segmentation. Development 132:503–513
31. Luo J, Sladek R, Bader JA, Matthyssen A, Rossant J, Giguère V (1997) Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature 388:778–782
32. Schaiff WT, Barak Y, Sadovsky Y (2006) The pleiotropic function of PPAR gamma in the placenta. Mol Cell Endocrinol 249(1–2):10–15
33. Barak Y, Sadovsky Y, Shalom-Barak T (2008) PPAR signaling in placental development and function. PPAR Res 2008:142082
34. Murthi P, Kalionis B, Cocquebert M, Rajaraman G, Chui A, Keogh RJ, Evain-Brion D, Fournier T (2013) Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. Placenta 34(4):299–309
35. Ding NZ, Teng CB, Ma H, Ni H, Ma XH, Xu LB, Yang ZM (2003) Peroxisome proliferator-activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization. Mol Reprod Dev 66:218–224
36. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D, Fournier T (2001) PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86:5017–5024
37. Fournier T, Handschuh K, Tsatsaris V, Evain-Brion D (2007) Involvement of PPARgamma in human trophoblast invasion. Placenta 28 Suppl A:S76–S81
38. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585–595
39. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T et al (1999) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4(4):597–609
40. Nadra K, Quignodon L, Sardella C, Joye E, Mucciolo A, Chrast R, Desvergne B (2010) PPARgamma in placental angiogenesis. Endocrinology 151(10):4969–4981
41. Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, Lappas M (2010) Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31:222–229
42. Waite LL, Louie RE, Taylor RN (2005) Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 90(2):620–626
43. Rodie VA, Young A, Jordan F, Sattar N, Greer IA, Freeman DJ (2005) Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 12(5):320–329
44. Weedon-Fekjær MS, Johnsen GM, Anthonisen EH, Sugulle M, Nebb HI, Duttaroy AK, Staff AC (2010) Expression of liver X receptors in pregnancies complicated by preeclampsia. Placenta 31:818–824
45. Pavan L, Hermouet A, Tsatsaris V, Thérond P, Sawamura T, Evain-Brion D, Fournier T (2004) Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145(10):4583–4591
46. Petkovich M, Brand NJ, Krust A, Chambon P (1987) Human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330(6147):444–450
47. Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330(6149):624–629
48. Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A (1988) Identification of a second human retinoic acid receptor. Nature 332(6167):850–853
49. Benbrook D, Lernhardt E, Pfahl M (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333(6174):669–672
50. Zelent A, Krust A, Petkovich M, Kastner P, Chambon P (1989) Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 339(6227):714–717
51. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P (1989) A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci 86(14):5310–5314
52. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345(6272):224–229
53. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10(9):940–954
54. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub M-P, LeMeur M, Chambon P (1993) High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci 90:7225–7229
55. Dollé P (2009) Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal 7:e006
56. Berry DC, Noy N (2009) All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor/and retinoic acid receptor. Mol Cell Biol 29:3286–3296
57. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83(6):841–850
58. Leid M, Kastner P, Chambon P (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17(10):427–433
59. Lalevee S, Anno YN, Chatagnon A, Samarut E, Poch O, Laudet V, Benoit G, Lecompte O, Rochette-Egly C (2011) Genome-wide in silico identification of new conserved and functional retinoic acid receptor response elements (direct repeats separated by 5 bp). J Biol Chem 286:33322–33334
60. Clagett-Dame M, DeLuca HF (2002) The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr 22:347–381
61. McCollum EV, Davis M (1913) The necessity of certain lipids in the diet during growth. J Biol Chem 15:167–175
62. Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66:606–630
63. Venkatachalam PS, Belavady B, Gopalan C (1962) Studies on vitamin A nutritional status of mothers and infants in poor communities of India. J Pediatr 61:262–268
64. Wilson JG, Roth CB, Warkany J (1953) An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92:189–217
65. Mason KE (1935) Fetal death, prolonged gestation, and difficult parturition in the rat as a result of vitamin A-deficiency. Am J Anat 57:303–349
66. Sommer A, Tarwotjo I, Djunaedi E, West KP Jr, Loeden AA, Tilden R, Mele L (1986) Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial. Lancet 1:1169–1173
67. Ross SA, McCaffery PJ, Drager UC, De Luca LM (2000) Retinoids in embryonal development. Physiol Rev 80:1021–1054
68. Cohlan SQ (1953) Excessive intake of vitamin A as a cause of congenital anomalies in the rat. Science 117:535–536
69. Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340(6229):140–144
70. Avantaggiato V, Acampora D, Tuorto F, Simeone A (1996) Retinoic acid induces stage-specific repatterning of the rostral central nervous system. Dev Biol 175(2):347–357
71. D’Ambrosio DN, Clugston RD, Blaner WS (2011) Vitamin A metabolism: an update. Nutrients 3:63–103
72. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H (2007) A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315:820–825
73. Parés X, Farrés J, Kedishvili N, Duester G (2008) Medium- and short-chain dehydrogenase/reductase gene and protein families: medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell Mol Life Sci 65:3936–3949
74. Niederreither K, Subbarayan V, Dollé P, Chambon P (1999) Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet 21:444–448
75. Chithalen JV, Luu L, Petkovich M, Jones G (2002) HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A. J Lipid Res 43:1133–1142
76. Reijntjes S, Blentic A, Gale E, Maden M (2005) The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo. Dev Biol 285:224–237
77. Wu L, Ross AC (2010) Acidic retinoids synergize with vitamin A to enhance retinol uptake and STRA6, LRAT, and CYP26B1 expression in neonatal lung. J Lipid Res 51:378–387
78. Bouillet P, Sapin V, Chazaud C, Messaddeq N, Décimo D, Dollé P, Chambon P (1997) Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein. Mech Dev 63:173–186
79. Kastner P, Mark M, Chambon P (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859–869
80. Mark M, Chambon P (2003) Functions of RARs and RXRs in vivo: genetic dissection of the retinoid signaling pathway. Pure Appl Chem 75:1709–1732
81. Mark M, Ghyselinck N, Chambon P (2009) Function of retinoic acid receptors during embryonic development. J Nucl Recept Signal Atlas 7:e002. doi:10.1621/nrs.07002
82. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H (2006) International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 58:712–725
83. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A, Chambon P (1994) Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120:2723–2748
84. Luo J, Sucov HM, Bader JA, Evans RM, Giguère V (1996) Compound mutants for retinoic acid receptor (RAR) beta and RAR alpha 1 reveal developmental functions for multiple RAR beta isoforms. Mech Dev 55:33–44
85. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch JL, Dolle P, Chambon P (1994) Genetic analysis of RXR α developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78:987–1003
86. Conlon RA (1995) Retinoic acid and pattern formation in vertebrates. Trends Genet 11:314–319
87. Sapin V, Ward SJ, Bronner S, Chambon P, Dollé P (1997) Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse. Dev Dyn 208:199–210
88. Sapin V, Bouillet P, Oulad-Abdelghani M, Dastugue B, Chambon P, Dollé P (2000) Differential expression of retinoic acid-inducible (Stra) genes during mouse placentation. Mech Dev 92:295–299
89. McC Howell, Thompson N, Pitt G (1964) Histology of the lesions produced in the reproductive tract of animals fed a diet deficient in vitamin A alcohol but containing vitamin A acid. J Reprod Fertil 7:251–258
90. Wendling O, Chambon P, Mark M (1999) RXRs are essential for early mouse development and placentogenesis. Proc Natl Acad Sci 96:547–551
91. Sapin V, Dollé P, Hindelang C, Kastner P, Chambon P (1997) Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses. Dev Biol 191:29–41
92. Datta K, Kulkarni AP (1996) Co-oxidation of all-trans retinol acetate by human term placental lipoxygenase and soybean lipoxygenase. Reprod Toxicol 10:105–112
93. Sapin V, Chaïb S, Blanchon L, Alexandre-Gouabau MC, Lémery D, Charbonne F, Gallot D, Jacquetin B, Dastugue B, Azais-Braesco V (2000) Esterification of vitamin A by the human placenta involves villous mesenchymal fibroblasts. Pediatr Res 48(4):565–572
94. Stephanou A, Handwerger S (1995) Retinoic acid and thyroid hormone regulate placental lactogen expression in human trophoblast cells. Endocrinology 136(3):933–938
95. Stephanou A, Handwerger S (1995) Identification of a composite steroid hormone response element on the human placental lactogen promoter. Mol Cell Endocrinol 112(1):123–129
96. Guibourdenche J, Alsat E, Soncin F, Rochette-Egly C, Evain-Brion D (1998) Retinoid receptors expression in human term placenta: involvement of RXR alpha in retinoid induced-hCG secretion. J Clin Endocrinol Metab 4:1384–1387
97. Roulier S, Rochette-Egly C, Rebut-Bonneton C, Porquet D, Evain-Brion D (1994) Nuclear retinoic acid receptor characterization in cultured human trophoblast cells: effect of retinoic acid on epidermal growth factor receptor expression. Mol Cell Endocrinol 2:165–173
98. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Heyman RA, Staels B, Auwerx J (1996) Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol 7:3350–3360
99. Kogai T, Liu YY, Richter LL, Mody K, Kagechika H, Brent GA (2010) Retinoic acid induces expression of the thyroid hormone transporter, monocarboxylate transporter 8 (Mct8). J Biol Chem 35:27279–27288
100. Hollung K, Rise CP, Drevon CA, Reseland JE (2004) Tissue-specific regulation of leptin expression and secretion by all-trans retinoic acid. J Cell Biochem 92(2):307–315
101. Holdsworth-Carson SJ, Permezel M, Riley C, Rice GE, Lappas M (2009) Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes. Placenta 30(2):176–186
102. Wang Y, Lin Q, Wang X, Lu P, Sheng Z, Ding C, Hong Y, Li W (2002) Expression of lethal gene mRNA on placenta villi in patients with spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi 37(9):542–545
103. Holdsworth-Carson SJ, Permezel M, Rice GE, Lappas M (2009) Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor. Reproduction 137(6):1007–1015
104. Nakanishi T, Nishikawa J, Hiromori Y, Yokoyama H, Koyanagi M, Takasuga S, Ishizaki J, Watanabe M, Isa S, Utoguchi N, Itoh N, Kohno Y, Nishihara T, Tanaka K (2005) Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Mol Endocrinol 19(10):2502–2516
105. Marceau G, Gallot D, Borel V, Lémery D, Dastugue B, Dechelotte P, Sapin V (2006) Molecular and metabolic retinoid pathways in human amniotic membranes. Biochem Biophys Res Commun. 346(4):1207–1216
106. Borel V, Marceau G, Gallot D, Blanchon L, Sapin V (2010) Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism. J Cell Mol Med 6B:1793–1805
107. Chen Y, Reese D (2013) A screen for disruptors of the retinol (vitamin A) signaling pathway. Birth Defects Res B 98:276–282
108. Dawson MI, Xia Z (2012) The retinoid X receptors and their ligands. Biochim Biophys Acta (BBA) Mol Cell Biol Lipids 1821:21–56
109. Thacher SM, Vasudevan J, Chandraratna RA (2000) Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des 6(1):25–58
110. Germain P, Kammerer S, Pérez E, Peluso-Iltis C, Tortolani D, Zusi FC, Starrett J, Lapointe P, Daris JP, Marinier A (2004) Rational design of RAR-selective ligands revealed by RARβ crystal stucture. EMBO Rep 5:877–882
111. Bourguet W, Germain P, Gronemeyer H (2000) Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21:381–388
112. Dilworth FJ, Chambon P (2001) Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20:3047–3054
113. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D (1995) Crystal structure of RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378(6558):681–689
114. de Lera AR, Bourguet W, Altucci L, Gronemeyer H (2007) Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nat Rev Drug Discov 6(10):811–820
115. Maire A, Alvarez S, Shankaranarayanan P, Lera AR, Bourguet W, Gronemeyer H (2012) Retinoid receptors and therapeutic applications of RAR/RXR modulators. Curr Top Med Chem 12(6):505–527
116. Germain P, Gaudon C, Pogenberg V, Sanglier S, Van Dorsselaer A, Royer CA, Lazar MA, Bourguet W, Gronemeyer H (2009) Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. Chem Biol 16(5):479–489
117. Elias PM (1987) Retinoid effects on the epidermis. Dermatologica 1:28–36
118. Gottlieb S, Hayes E, Gilleaudeau P, Cardinale I, Gottlieb AB, Krueger JG (1996) Cellular actions of etretinate in psoriasis enhanced epidermal differentiation and reduced cell -mediated inflammation are unexpected outcomes. J Cutan Pathol 23(5):404–418
119. Gisondi P, Del Giglio M, Cotena C, Girolomoni G (2008) Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 158(6):1345–1349
120. Lee CS, Li K (2009) A review of acitretin for the treatment of psoriasis. Expert Opin Drug Saf 8(6):769–779
121. Mérot Y, Camenzind M, Geiger JM, Saurat JH (1987) Arotinoid ethyl ester (Ro 13-6298): a long term pilot study in various dermatoses. Acta Derm Venereol 67(3):237–242
122. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1(3):181–193
123. Widschwendter M, Berger J, Müller HM, Zeimet AG, Marth C (2001) Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6(2):193–201
124. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R (1994) Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54(13):3580–3587
125. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK (1995) Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332(21):1405–1410
126. Ablain J, de Thé H (2014) Retinoic acid signaling in cancer: the parable of acute promyelocytic leukemia. Int J Cancer 135(10):2262–2272
127. Shalita AR, Armstrong RB, Leyden JJ, Pochi PE, Strauss JS (1988) Isotretinoin revisited. Cutis 42(6A):1–19
128. Perry MD, McEvoy GK (1983) Isotretinoin: new therapy for severe acne. Clin Pharmacol 2(1):12–19
129. Brogden RN, Goa KE (1997) Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 53(3):511–519
130. Ismadi SD, Olson JA (1982) Dynamics of the fetal distribution and transfer of vitamin A between rat fetuses and their mother. Int J Vitam Nutr Res 52(2):112–119
131. Donoghue S, Richardson DW, Sklan D, Kronfeld DS (1982) Placental transport of retinol in sheep. J Nutr 112(11):2197–2203
132. Shukla RR, Kumar V, Banerjee R, Misra UK (1986) Placental transfer and fetal distribution of 3H-retinoic acid in rats. Int J Vitam Nutr Res 56(1):29–33
133. Wassef L, Quadro L (2011) Uptake of dietary retinoids at the maternal–fetal barrier: in vivo evidence for the role of lipoprotein lipase and alternative pathways. J Biol Chem 286(37):32198–32207
134. Marceau G, Gallot D, Lemery D, Sapin V (2007) Metabolism of retinol during mammalian placental and embryonic development. Vitam Horm 75:97–115
135. Ortega-Senovilla H, Alvino G, Taricco E, Cetin I, Herrera E (2009) Enhanced circulating retinol and non-esterified fatty acids in pregnancies complicated with intrauterine growth restriction. Clin Sci (Lond) 118(5):351–358
136. Kutasy B, Pes L, Friedmacher F, Paradisi F, Puri P (2014) Nitrofen increases total retinol levels in placenta during lung morphogenesis in the nitrofen model of congenital diaphragmatic hernia. Pediatr Surg Int 30(10):1017–1022
137. Sulik KK, Dehart DB, Rogers JM, Chernoff N (1995) Teratogenicity of low doses of all-trans retinoic acid in presomite mouse embryos. Teratology 51(6):398–403
138. Creech Kraft J, Kochhar DM, Scott WJ Jr, Nau H (1987) Low Teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer. Toxicol Appl Pharmacol 87:474–482
139. Nau H (2001) Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 45(5):S183–S187
140. Tsukada M, Schröder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, Orfanos CE, Zouboulis CC (2000) 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol 115(2):321–327
141. Blaner WS (2001) Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol 45(5):S129–S135
142. Kochhar DM, Jiang H, Penner JD, Heyman RA (1995) Placental transfer and developmental effects of 9-cis retinoic acid in mice. Teratology 51(4):257–265
143. Collins MD, Tzimas G, Bürgin H, Hummler H, Nau H (1995) Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit. Toxicol Appl Pharmacol 130(1):9–18
144. Sass JO, Hartmann J, Chahoud I, Shroot B, Nau H (1995) Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding protein. Toxicol Lett 75(1–3):159–168
145. Willhite CC, Lovey A, Eckhoff C (2000) Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223. Toxicol Appl Pharmacol 164(2):171–175
146. Crettaz M, Baron A, Siegenthaler G, Hunziker W (1990) Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem J 272(2):391–397
147. Kochhar DM, Penner JD (1992) Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid. Teratology 45(6):637–645
148. Loeliger P, Bollag W, Mayer H (1980) Arotinoids, a new class of highly active retinoids. Eur J Med Chem 15:9–15
149. Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B, Nau H (2000) Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch Toxicol 73(10–11):547–556
150. Brown NA, Fabro S (1983) The value of animal teratogenicity testing for predicting human risk. Clin Obstet Gynecol 26(2):467–477
151. Schardein JL, Schwetz BA, Kenel MF (1985) Species sensitivities and prediction of teratogenic potential. Environ Health Perspect 61:55–67
152. Buresh JJ, Urban TJ (1970) Palatal abnormalities induced by cortisone and corticosterone in the rat. J Acad Gen Dent 18(2):34–37
153. Buttar HS, Dupuis I, Khera KS (1976) Fetotoxicity of trimethadione and paramethadione in rats. Toxicol Appl Pharmacol 37:126
154. Schwetz BA, Smith FA, Staples RE (1978) Teratogenic potential of ethanol in mice, rats and rabbits. Teratology 18:385–392
155. Neubert D, Merker HJ, Nau H and Langman J (1978) Role of pharmacokinetics in prenatal and perinatal toxicology: third symposium on prenatal development, Berlin, pp 499–506
156. Centers for Disease Control (1984) Isotretinoin—a newly recognized human teratogen. Morb Mortal Wkly Rep 33:171–173
157. Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD (2005) Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A 136(2):117–121
158. Pugashetti R, Shinkai K (2013) Treatment of acne vulgaris in pregnant woman. Dermatol Ther 26(4):302–311
159. Nulman I, Berkovitch M, Klein J, Pastuszak A, Lester RS, Shear N, Koren G (1998) Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. J Clin Pharmacol 38(10):926–930
160. Yang D, Hladnik L (2009) Treatment of acute promyelocytic leukemia during pregnancy. Pharmacotherapy 29(6):709–724
161. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 113(9):1875–1891
162. Culligan DJ, Merriman L, Kell J, Parker J, Jovanovic JV, Smith N, Grimwade D (2007) The management of acute promyelocytic leucemia presenting during pregnancy. Clin Leukemia 1:183–191
163. Crowe DL, Chandraratna RA (2004) A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res 6(5):R546–R555
164. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503–1506
165. Shulman AI, Mangelsdorf DJ (2005) Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med 353:604–615
166. Lowe MN, Plosker GL (2000) Bexarotene. Am J Clin Dermatol 1:245–250 (discussion 251–252)
167. Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, Duvic M (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340(14):1075–1079
168. Zhang C, Duvic M (2003) Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol Ther 16:322–330
169. Michellys PY, Ardecky RJ, Chen JH, Crombie DL, Etgen GJ, Faul MM, Faulkner AL, Grese TA, Heyman RA, Karanewsky DS, Klausing K, Leibowitz MD, Liu S, Mais DA, Mapes CM, Marschke KB, Reifel-Miller A, Ogilvie KM, Rungta D, Thompson AW, Tyhonas JS, Boehm MF (2003) Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J Med Chem 46(13):2683–2696
170. Michellys PY, Ardecky RJ, Chen JH, D’Arrigo J, Grese TA, Karanewsky DS, Leibowitz MD, Liu S, Mais DA, Mapes CM, Montrose-Rafizadeh C, Ogilvie KM, Reifel-Miller A, Rungta D, Thompson AW, Tyhonas JS, Boehm MF (2003) Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids. J Med Chem 46(19):4087–4103